Discovering that your prostate-specific antigen (PSA) is elevated can be stressful and confusing for many men. PSA testing is an important tool for detecting potential prostate issues, including prostate cancer, but it isn’t always definitive. While an elevated PSA often leads to a recommendation for a biopsy, there are several additional tests and imaging options available that can help guide decisions, reduce unnecessary procedures, and provide peace of mind.
At Conrad Pearson Clinic, serving the Memphis area, we provide advanced prostate evaluation, including the latest imaging techniques and minimally invasive biopsy options, so men can make informed decisions about their health.
Understanding PSA and Its Limitations
PSA is a protein produced by the prostate gland. Elevated PSA levels may indicate prostate cancer, but they can also result from other non-cancerous conditions, including:
- Benign prostatic hyperplasia (BPH) – Prostate enlargement that can affect urine flow
- Prostatitis – Inflammation of the prostate
- Recent sexual activity or vigorous exercise
- Urinary tract infections or catheter use
Because PSA alone cannot distinguish between cancerous and benign conditions, additional testing is often recommended before moving to a biopsy. This approach helps prevent unnecessary procedures and allows for a more precise understanding of a patient’s prostate health.
Advanced Testing Options Before a Prostate Biopsy
For men, several tests are available to assess prostate cancer risk more accurately.:
Repeat PSA test
When a PSA is elevated typically one of the first things to do is repeat a PSA test. A repeat PSA test is important because a single elevated result doesn’t necessarily indicate prostate cancer. PSA levels can rise temporarily due to factors like infection, inflammation, or recent activity, so repeating the test helps confirm whether the elevation is persistent. It also allows doctors to track changes over time, reducing the risk of unnecessary procedures and guiding appropriate next steps. If still elevated on a repeat PSA test then it is time to consider ancillary testing.
IsoPSA Testing
IsoPSA is a newer biomarker that helps stratify prostate cancer risk. Unlike traditional PSA tests, IsoPSA provides a more detailed view of a patient’s likelihood of having clinically significant prostate cancer. A low IsoPSA result can indicate a lower risk, which may help some patients avoid an immediate biopsy and explore other monitoring options.
ExoDX (EPI) test
The ExoDx (EPI) test is a simple urine test used when PSA levels are elevated, typically in the 2–10 range, to help determine the risk of having a more serious form of prostate cancer. It is mainly used to decide whether a biopsy is necessary, helping avoid unnecessary procedures. By providing additional information beyond PSA, it can guide next steps and is often used alongside repeat PSA tests or MRI for a more accurate assessment. It is generally intended for men who have not had a prior biopsy, and its accuracy may be influenced by factors like medications such finasteride, which can alter PSA-related biology. Results may also be affected if the test is done too soon after a digital rectal exam (DRE).
MRI of the Prostate
MRI can identify suspicious regions in the prostate and help doctors pinpoint exactly where to look if a biopsy is needed, making the biopsy more accurate. This advanced imaging allows urologists to focus on areas that appear abnormal, improving diagnostic accuracy while reducing unnecessary biopsies. For many men, MRI is an invaluable step before considering invasive procedures.
Biopsy Options: Traditional vs. Transperineal
If a prostate biopsy is needed, there are two main approaches:
- Traditional Transrectal Biopsy – Involves sampling the prostate through the rectum. This method has been widely used for decades and carries a small risk of infection.
- Transperineal Biopsy – Performed through the skin between the scrotum and rectum, this approach is increasingly recommended in European guidelines. It has a very low infection risk and may allow for more accurate sampling of difficult-to-reach areas, and is growing in popularity in the U.S.
Combining advanced imaging techniques with a prostate biopsy can help target suspicious areas, reduce unnecessary sampling, and provide a more complete picture of prostate health.
Why a Personalized Approach Matters
Not all patients with an elevated PSA require a biopsy, and no two patients are exactly alike. A personalized evaluation considers factors such as PSA levels and trends over time, family history of prostate cancer, age and overall health, and any prior biopsy results or imaging findings. By tailoring testing and biopsy strategies to each individual patient, urologists can help ensure men receive safe, effective, personalized care.
Benefits of Early and Accurate Evaluation
Early and precise evaluation of an elevated PSA offers multiple benefits:
- Reduced risk of unnecessary biopsies
- More accurate detection of clinically significant prostate cancers
- Lower risk of infection with transperineal biopsy
- Better treatment planning through advanced imaging like MRI and PSMA PET scans
- Peace of mind for patients navigating elevated PSA results
For men in the Mid-South, access to advanced diagnostic tools and minimally invasive biopsy techniques means better outcomes and less stress.
The Takeaway
The team at Conrad Pearson Clinic specializes in advanced prostate care with expertise in modern testing, imaging, and minimally invasive biopsy options. An elevated PSA doesn’t automatically indicate prostate cancer, but it does require further careful evaluation. Advanced testing, including isoPSA, ExoDX, and MRI, can help identify risk and guide whether a biopsy is necessary. When a biopsy is recommended, Dr. Matthew Sims specializes in newer transperineal biopsies that can be done without bowel prep and minimize the risk of infection.
By combining state-of-the-art diagnostics with personalized care, patients can navigate elevated PSA results with confidence, accuracy, and peace of mind.
